Showing results (161-170 of 184) with videos related to

Sort By:
Pageof 19
Plos One|October 3, 2014
Association of drug transporter expression with mortality and progression-free survival in stage IV head and neck squamous cell carcinomaRolf Warta, Dirk Theile, Carolin Mogler, et al.
Journal of Cancer Research and Clinical Oncology|December 5, 2024
Developing an instrument to measure the quality of social work cancer counseling regarding return to work - psychometric properties of the German Quality of Cancer Counseling Questionnaire-Return to Work (QCCQ-W)Clara Breidenbach, Sabine Schneider, Marie Rösler, et al.
Clinical Pharmacology and Therapeutics|August 8, 2006
Potent cytochrome P450 2C19 genotype-related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavirGerd Mikus, Verena Schöwel, Magdalena Drzewinska, et al.
Cancer Letters|April 2, 2016
The phytoestrogen genistein enhances multidrug resistance in breast cancer cell lines by translational regulation of ABC transportersJuan Pablo Rigalli, Guillermo Nicolás Tocchetti, Maite Rocío Arana, et al.
Frontiers in Pharmacology|April 24, 2023
Evaluation of the drug-drug interaction potential of the novel hepatitis B and D virus entry inhibitor bulevirtide at OATP1B in healthy volunteersVanessa Zhu, Jürgen Burhenne, Johanna Weiss, et al.
Basic & Clinical Pharmacology & Toxicology|October 8, 2014
The effect of induction of CYP3A4 by St John's wort on ambrisentan plasma pharmacokinetics in volunteers of known CYP2C19 genotypeChristoph Markert, Ida Maria Kastner, Regina Hellwig, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 30, 2014
Influence of St. John's wort on the steady-state pharmacokinetics and metabolism of bosentanChristoph Markert, Prisca Ngui, Regina Hellwig, et al.
BMC Pharmacology & Toxicology|August 30, 2019
Unexpected excessive apixaban exposure: case report of a patient with polymorphisms of multiple apixaban elimination pathwaysAndrea Huppertz, Caspar Grond-Ginsbach, Chris Dumschat, et al.
European Journal of Drug Metabolism and Pharmacokinetics|December 20, 2023
Evaluation of Hydroxychloroquine as a Perpetrator on Cytochrome P450 (CYP) 3A and CYP2D6 Activity with Microdosed Probe Drugs in Healthy VolunteersFelicitas Stoll, Antje Blank, Gerd Mikus, et al.
Paediatric Drugs|February 27, 2017
Use of Fentanyl in Adolescents with Clinically Severe Obesity Undergoing Bariatric Surgery: A Pilot StudyJanelle D Vaughns, Victoria C Ziesenitz, Elaine F Williams, et al.
Pageof 19